» Articles » PMID: 31638099

Effects of MiR-219/miR-338 on Microglia and Astrocyte Behaviors and Astrocyte-oligodendrocyte Precursor Cell Interactions

Overview
Date 2019 Oct 23
PMID 31638099
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

MiR-219 and miR-338 (miR-219/miR-338) are oligodendrocyte-specific microRNAs. The overexpression of these miRs in oligodendrocyte precursor cells promotes their differentiation and maturation into oligodendrocytes, which may enhance axonal remyelination after nerve injuries in the central nervous system (CNS). As such, the delivery of miR-219/miR-338 to the CNS to promote oligodendrocyte precursor cell differentiation, maturation and myelination could be a promising approach for nerve repair. However, nerve injuries in the CNS also involve other cell types, such as microglia and astrocytes. Herein, we investigated the effects of miR-219/miR-338 treatment on microglia and astrocytes in vitro and in vivo. We found that miR-219/miR-338 diminished microglial expression of pro-inflammatory cytokines and suppressed astrocyte activation. In addition, we showed that miR-219/miR-338 enhanced oligodendrocyte precursor cell differentiation and maturation in a scratch assay paradigm that re-created a nerve injury condition in vitro. Collectively, our results suggest miR-219/miR-338 as a promising treatment for axonal remyelination in the CNS following nerve injuries. All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC), Nanyang Technological University (approval No. A0309 and A0333) on April 27, 2016 and October 8, 2016.

Citing Articles

MicroRNA-219 in the central nervous system: a potential theranostic approach.

Shamaeizadeh N, Mirian M Res Pharm Sci. 2025; 19(6):634-655.

PMID: 39911893 PMC: 11792714. DOI: 10.4103/RPS.RPS_163_23.


Oligodendrocyte Progenitors in Glial Scar: A Bet on Remyelination.

Marangon D, Castro E Silva J, Cerrato V, Boda E, Lecca D Cells. 2024; 13(12.

PMID: 38920654 PMC: 11202012. DOI: 10.3390/cells13121024.


Remyelination in multiple sclerosis from the miRNA perspective.

Maciak K, Dziedzic A, Saluk J Front Mol Neurosci. 2023; 16:1199313.

PMID: 37333618 PMC: 10270307. DOI: 10.3389/fnmol.2023.1199313.


Modulating neuroinflammation through molecular, cellular and biomaterial-based approaches to treat spinal cord injury.

Lee C, Chooi W, Ng S, Chew S Bioeng Transl Med. 2023; 8(2):e10389.

PMID: 36925680 PMC: 10013833. DOI: 10.1002/btm2.10389.


Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells.

Enders M, Weier A, Chunder R, An Y, Bremm F, Feigenspan A Int J Mol Sci. 2023; 24(4).

PMID: 36835129 PMC: 9960570. DOI: 10.3390/ijms24043716.


References
1.
Alizadeh A, Dyck S, Karimi-Abdolrezaee S . Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci. 2015; 8:35. PMC: 4515562. DOI: 10.3389/fnmol.2015.00035. View

2.
Nesic O, Xu G, McAdoo D, High K, Hulsebosch C . IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma. 2001; 18(9):947-56. DOI: 10.1089/089771501750451857. View

3.
Loane D, Byrnes K . Role of microglia in neurotrauma. Neurotherapeutics. 2010; 7(4):366-77. PMC: 2948548. DOI: 10.1016/j.nurt.2010.07.002. View

4.
Lu Q, Yuk D, Alberta J, Zhu Z, Pawlitzky I, Chan J . Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron. 2000; 25(2):317-29. DOI: 10.1016/s0896-6273(00)80897-1. View

5.
Kirkley K, Popichak K, Afzali M, Legare M, Tjalkens R . Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity. J Neuroinflammation. 2017; 14(1):99. PMC: 5418760. DOI: 10.1186/s12974-017-0871-0. View